Aberrant expression of ZCCHC4 is associated with cancer stages, lymph node metastasis (LNM), and tumor histology, and poorer Overall Survival (OS) in esophageal cancer. Here, ZCCHC4 is linked to metastatic malignant neoplasm in the lymph nodes.